|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 139.52 USD | +0.09% |
|
-2.82% | -19.83% |
Company Valuation: Insmed Incorporated
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 3,224 | 2,707 | 4,433 | 12,351 | 37,118 | 30,074 | - | - |
| Change | - | -16.05% | 63.79% | 178.59% | 200.52% | -18.98% | - | - |
| Enterprise Value (EV) 1 | 3,089 | 2,863 | 4,993 | 12,209 | 36,229 | 29,359 | 29,278 | 28,452 |
| Change | - | -7.33% | 74.42% | 144.52% | 196.74% | -18.96% | -0.28% | -2.82% |
| P/E ratio | -7.02x | -5.11x | -5.8x | -12.4x | -27.1x | -51.9x | 171x | 36.1x |
| PBR | 6.82x | 30.8x | -13.1x | 39.7x | 46.9x | 90.6x | 52.1x | 21.9x |
| PEG | - | -6.61x | -0.2x | -2.88x | -1.8x | 0.9x | -1x | 0x |
| Capitalization / Revenue | 17.1x | 11x | 14.5x | 34x | 61.2x | 17.9x | 11x | 7.82x |
| EV / Revenue | 16.4x | 11.7x | 16.4x | 33.6x | 59.7x | 17.5x | 10.7x | 7.4x |
| EV / EBITDA | -8.58x | -6.4x | -7.14x | -14.1x | -29.4x | -57.7x | 365x | 38x |
| EV / EBIT | -8.24x | -6.26x | -7.04x | -13.9x | -29.1x | -56.9x | 114x | 28.7x |
| EV / FCF | -8.34x | -6.98x | -9.09x | -17.3x | -37.4x | -49.8x | -899x | 36x |
| FCF Yield | -12% | -14.3% | -11% | -5.78% | -2.67% | -2.01% | -0.11% | 2.78% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -3.88 | -3.91 | -5.34 | -5.57 | -6.42 | -2.689 | 0.8167 | 3.869 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 188.5 | 245.4 | 305.2 | 363.7 | 606.4 | 1,681 | 2,725 | 3,844 |
| EBITDA 1 | -359.8 | -447 | -699 | -867.2 | -1,230 | -508.8 | 80.12 | 748.7 |
| EBIT 1 | -375.1 | -457.3 | -709.6 | -878.3 | -1,247 | -516 | 255.8 | 992.3 |
| Net income 1 | -434.7 | -481.5 | -749.6 | -913.8 | -1,277 | -573.2 | 170.9 | 896 |
| Net Debt 1 | -135.5 | 155.8 | 559.5 | -142.4 | -889.1 | -714.5 | -796.2 | -1,622 |
| Reference price 2 | 27.24 | 19.98 | 30.99 | 69.04 | 174.04 | 139.52 | 139.52 | 139.52 |
| Nbr of stocks (in thousands) | 1,18,372 | 1,35,477 | 1,43,062 | 1,78,903 | 2,13,273 | 2,15,552 | - | - |
| Announcement Date | 17/02/22 | 23/02/23 | 22/02/24 | 20/02/25 | 19/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -51.88x | 17.46x | -57.7x | -.--% | 3.01TCr | |
| 41.62x | 9.71x | 35.05x | 0.03% | 4.35TCr | |
| 15.77x | 5.61x | 12.36x | 1.9% | 3.99TCr | |
| -17.43x | 4.11x | -7.72x | -.--% | 2.16TCr | |
| 26.89x | 5.54x | 15.37x | -.--% | 1.86TCr | |
| 21.84x | 4.15x | 13.57x | -.--% | 1.65TCr | |
| -318.22x | 26.4x | 1453.35x | -.--% | 1.31TCr | |
| -13.71x | 6123.95x | -17.5x | -.--% | 1.2TCr | |
| -162.05x | 39.38x | -156.41x | -.--% | 1.16TCr | |
| 13.46x | 3.74x | 8.87x | -.--% | 1.07TCr | |
| Average | -44.37x | 624.01x | 129.92x | 0.19% | 2.17TCr | |
| Weighted average by Cap. | -21.60x | 348.14x | 81.43x | 0.35% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- INSM Stock
- Valuation Insmed Incorporated
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition